Single-dose faricimab in treatment-experiences eyes with nARMD: Case 2

Commentary
Video

Moritz Pettenkofer, MD, presents a case of a 75-year-old male patient with nARMD who has had 53 injections of anti-VEGF therapy over 4 years.

Related Videos
Roger Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME | Image Credit: Bay Area Retina Associates
Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD | Image Credit: LinkedIn
Dolly Chang, MD, PhD | Image Credit: LinkedIn
Daniel Su, MD: | Image Credit: Retina Vitreous-Associates Medical Group
Daniela Ferrara, MD, PhD: Machine Learning Predicts Functional Outcomes in DME | Image Credit: Ophthalmology Innovation Summit
Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:
Peter A. Campochiaro, MD: RGX-314 for nAMD | Image Credit: Johns Hopkins Medicine
Related Content
ARVO President Srinivas R. Sadda, MD, Visualizes Ophthalmology's Future

ARVO President Srinivas R. Sadda, MD, Visualizes Ophthalmology's Future

May 13th 2024
Article
"New Insight with Veeral Sheth, MD" logo | Image Credit: HCPLive

New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk

February 29th 2024
Podcast
| Image Credit: Berner Augenklinik

Baseline Features in nAMD Not Predictive of Aflibercept 8 mg Intervals

May 7th 2024
Article
New Insight with Veeral Sheth, MD Podcast logo | Image Credit: HCPLive

New Insight: Reengaging the Retina Community in 2024 with David Eichenbaum, MD and Roger Goldberg, MD

February 8th 2024
Podcast
| Image Credit: Stanford University

HORNBILL: BI 764524 Meets Safety Endpoints in Diabetic Macular Ischemia

May 6th 2024
Article
Ophthalmology Month in Review: April 2024 | Image Credit: HCPLive

Ophthalmology Month in Review: April 2024

May 2nd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.